Literature DB >> 20136843

N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels.

Neelam Parmar1, W-S Vanessa Ho.   

Abstract

BACKGROUND AND
PURPOSE: N-arachidonoyl glycine (NAGly) is an endogenous lipid that is structurally similar to the endocannabinoid, N-arachidonoyl ethanolamide (anandamide). While NAGly does not activate cannabinoid receptors, it exerts cannabimimetic effects in pain regulation. Here, we have determined if NAGly, like anandamide, modulates vascular tone. EXPERIMENTAL APPROACH: In rat isolated small mesenteric arteries, the relaxant responses to NAGly were characterized. Effects of N-arachidonoyl serine and N-arachidonoyl gamma-aminobutyric acid were also examined. KEY
RESULTS: In endothelium-intact arteries, NAGly-induced relaxation (pEC(50%)= 5.7 +/- 0.2; relaxation at 30 microM = 98 +/- 1%) was attenuated by l-NAME (a nitric oxide synthase inhibitor) or iberiotoxin [selective blocker of large conductance Ca(2+)-activated K(+) channels (BK(Ca))], and abolished by high extracellular K(+) concentration. Endothelial removal reduced the potency of NAGly, and the resultant relaxation was inhibited by iberiotoxin, but not l-NAME. NAGly responses were sensitive to the novel cannabinoid receptor antagonist O-1918 independently of endothelial integrity, whereas pertussis toxin, which uncouples G(i/o) proteins, attenuated NAGly relaxation only in endothelium-intact arteries. Treatments with antagonists for CB(1), CB(2) and TRPV1 receptors, or inhibitors of fatty acid amide hydrolase and COX had no effect. The two other arachidonoyl amino acids also induced iberiotoxin- and L-NAME-sensitive relaxations. CONCLUSION AND IMPLICATIONS: NAGly acts as a vasorelaxant predominantly via activation of BK(Ca) in rat small mesenteric arteries. We suggest that NAGly activates an unknown G(i/o)-coupled receptor, stimulating endothelial release of nitric oxide which in turn activates BK(Ca) in the smooth muscle. In addition, NAGly might also activate BK(Ca) through G(i/o)- and nitric oxide-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136843      PMCID: PMC2931560          DOI: 10.1111/j.1476-5381.2009.00622.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent.

Authors:  Somnath Mukhopadhyay; Barry M Chapnick; Allyn C Howlett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

3.  Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.

Authors:  S M Huang; T Bisogno; T J Petros; S Y Chang; P A Zavitsanos; R E Zipkin; R Sivakumar; A Coop; D Y Maeda; L De Petrocellis; S Burstein; V Di Marzo; J M Walker
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

4.  Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.

Authors:  W-S Vanessa Ho; C Robin Hiley
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

Authors:  László Offertáler; Fong-Ming Mo; Sándor Bátkai; Jie Liu; Malcolm Begg; Raj K Razdan; Billy R Martin; Richard D Bukoski; George Kunos
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

6.  Regulation of anandamide tissue levels by N-arachidonylglycine.

Authors:  Sumner H Burstein; Susan M Huang; Timothy J Petros; Ronald G Rossetti; J Michael Walker; Robert B Zurier
Journal:  Biochem Pharmacol       Date:  2002-10-01       Impact factor: 5.858

7.  Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.

Authors:  R White; W S Ho; F E Bottrill; W R Ford; C R Hiley
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.

Authors:  Jeffery J Prusakiewicz; Philip J Kingsley; Kevin R Kozak; Lawrence J Marnett
Journal:  Biochem Biophys Res Commun       Date:  2002-08-23       Impact factor: 3.575

9.  In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.

Authors:  H Iwamura; H Suzuki; Y Ueda; T Kaya; T Inaba
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

10.  Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.

Authors:  W-S Vanessa Ho; Sheila M Gardiner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

View more
  24 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?

Authors:  W-S V Ho
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Resolution of inflammation by N-arachidonoylglycine.

Authors:  Sumner H Burstein; Catherine A McQuain; Alonzo H Ross; Rebecca A Salmonsen; Robert E Zurier
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 5.  Endothelial atypical cannabinoid receptor: do we have enough evidence?

Authors:  Alexander I Bondarenko
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2017-12-20       Impact factor: 4.432

7.  N-Amino acid linoleoyl conjugates: anti-inflammatory activities.

Authors:  Sumner Burstein; Catherine McQuain; Rebecca Salmonsen; Benjamin Seicol
Journal:  Bioorg Med Chem Lett       Date:  2011-12-16       Impact factor: 2.823

8.  The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.

Authors:  Anusha Penumarti; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2014-01-15       Impact factor: 4.030

9.  The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats.

Authors:  Asmaa I Matouk; Ashraf Taye; Mohamed A El-Moselhy; Gehan H Heeba; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2017-01       Impact factor: 3.105

Review 10.  Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.

Authors:  Virna Margarita Martín Giménez; Sandra Edith Noriega; Diego Enrique Kassuha; Lucía Beatriz Fuentes; Walter Manucha
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.